Practice Area

We are known for acting for life sciences clients on the full range of transactional matters, including M&A, joint ventures, strategic collaborations and licensing deals.

Our team understands the regulatory, IP, and commercial dynamics that shape transactions in this sector, from early-stage biotech investments to complex cross-border acquisitions. Clients rely on us to structure and execute deals that support innovation and maximise long-term value. Our deep, cross-disciplinary expertise enables us to advise life sciences companies on transactions with clarity and confidence, ensuring alignment with their strategic and scientific objectives.

Latest

View All
News Pharma
News Pharma
News Regulatory
News Regulatory

Our Services

  • Strategic alliances
  • Acquisitions and acquisition financing
  • Venture capital transactions
  • Multi-source financing
  • Corporate reorganisations and restructuring

Recent Work

  • Advising Bertelsmann on its acquisition of Medicines.ie, Ireland’s official source of information on authorised medicines.

  • Advising Vimian Group, a Swedish animal health company, on its acquisition of iM3 Dental Limited.

  • Advising Endotronix Inc. on its high profile merger with Fortune 500 company, Edwards Lifesciences.

  • Advising Elkstone on investments into medtech businesses such as CroíValve and HidraMed Solutions.

  • Acting for Biosynth on its acquisition of the Fitzgerald Industries life sciences supply business from Trinity Biotech.

Related Practice Areas

Dedicated Team

View All
Martin Kelleher

Martin Kelleher

Partner

Head of Corporate Transactional

+353 86 810 7838 mkelleher@mhc.ie View Profile on MHC.ie
Ron Boucher

Ron Boucher

Partner

Head of London Office Transactional

+44 7540 418 516 rboucher@mhc.ie View Profile on MHC.ie
Anne Harkin

Anne Harkin

Partner

Transactional

+353 86 029 5141 aharkin@mhc.ie View Profile on MHC.ie